We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| AC Immune SA | NASDAQ:ACIU | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.97 | 3.80 | 4.68 | 0 | 12:00:17 |
From Jun 2022 to Jun 2024
By Jeffrey T. Lewis
AC Immunity's shares rose 18% after the biopharmaceutical company got fast-track designation for a treatment for Alzheimer's Disease from the Food and Drug Administration.
Shares reached $2.33 in pre-market trading and were down 3% from the end of last year through Monday's close.
The company said Tuesday before trading began that its anti-amyloid beta active immunotherapy-candidate, ACI-24.060, got the designation, which is intended to speed up the development and review of drugs that treat serious conditions and fill an unmet medical need.
The goal of the designation is to speed important new drugs through the approval process and get them to patients as quickly as possible, according to the FDA
Write to Jeffrey T. Lewis at jeffrey.lewis@wsj.com
(END) Dow Jones Newswires
June 27, 2023 07:56 ET (11:56 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year AC Immune Chart |
1 Month AC Immune Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
